Herriot Tabuteau
CHIEF EXECUTIVE OFFICER at Axsome Therapeutics Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Axsome Therapeutics Inc., 3 years.
Chief executive roles
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Axsome Therapeutics Inc. June 7, 202498.4%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 6, 2026 | Axsome Therapeutics Inc. | Option exercise | +4,660 | $4.95 | $23,067 |
| Aug 6, 2026 | Axsome Therapeutics Inc. | Open-market sale | −4,660 | $213.95 | $997,007 |
| Aug 5, 2026 | Axsome Therapeutics Inc. | Option exercise | +45,004 | $4.95 | $222,770 |
| Aug 5, 2026 | Axsome Therapeutics Inc. | Open-market sale | −45,004 | $212.01 | $9,541,298 |
| Jul 1, 2026 | Axsome Therapeutics Inc. | Option exercise | +49,666 | $4.95 | $245,847 |
| Jul 1, 2026 | Axsome Therapeutics Inc. | Open-market sale | −49,666 | $240.25 | $11,932,257 |
| Jun 9, 2026 | Axsome Therapeutics Inc. | Option exercise | +49,670 | $4.95 | $245,867 |
| Jun 9, 2026 | Axsome Therapeutics Inc. | Open-market sale | −49,670 | $241.01 | $11,970,967 |
| Feb 2, 2026 | Axsome Therapeutics Inc. | Option exercise | +32,410 | $8.02 | $259,928 |
| Feb 2, 2026 | Axsome Therapeutics Inc. | Open-market sale | −32,410 | $185.60 | $6,015,296 |
| Jan 7, 2026 | Axsome Therapeutics Inc. | Option exercise | +31,261 | $8.02 | $250,713 |
| Jan 7, 2026 | Axsome Therapeutics Inc. | Open-market sale | −31,261 | $170.38 | $5,326,249 |
| Jan 6, 2026 | Axsome Therapeutics Inc. | Option exercise | +29,450 | $8.02 | $236,189 |
| Jan 6, 2026 | Axsome Therapeutics Inc. | Open-market sale | −29,450 | $172.33 | $5,075,119 |
| Jan 5, 2026 | Axsome Therapeutics Inc. | Option exercise | +78,703 | $8.02 | $631,198 |
Questions about Herriot Tabuteau
What boards is Herriot Tabuteau on?
Herriot Tabuteau sits on the board of Axsome Therapeutics Inc.
What company is Herriot Tabuteau the CEO of?
Herriot Tabuteau is CHIEF EXECUTIVE OFFICER of Axsome Therapeutics Inc.
How long has Herriot Tabuteau served on boards?
Our records show at least 4 years of board service across 1 board, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.